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Spironolactone and Its Main Metabolite, Canrenoic Acid,
Block Human Ether-a-Go-Go–Related Gene Channels
Ricardo Caballero, BPharm, PhD*; Ignacio Moreno, BPharm*; Teresa González, BSc;
Cristina Arias, BSc; Carmen Valenzuela, BSc, PhD;
Eva Delpón, BPharm, PhD; Juan Tamargo, MD, PhD, FESC
Background—It has been demonstrated that spironolactone (SP) decreases the QT dispersion in chronic heart failure. In
this study, the effects of SP and its metabolite, canrenoic acid (CA), on human ether-a-go-go–related gene (HERG)
currents were analyzed.
Methods and Results—HERG currents elicited in stably transfected Chinese hamster ovary cells were measured with the
whole-cell patch-clamp technique. SP decreased HERG currents in a concentration-dependent manner (IC5023.01.5
mol/L) and shifted the midpoint of the activation curve to more negative potentials (Vh13.13.4 versus
18.93.6 mV, P0.05) without modifying the activation and deactivation kinetics. SP-induced block (1 mol/L)
appeared at the range of membrane potentials coinciding with that of channel activation, and thereafter, it remained
constant, reaching 24.73.8% at 60 mV (n6, P0.05). CA (0.01 nmol/L to 500 mol/L) blocked HERG channels
in a voltage- and frequency-independent manner. CA at 1 nmol/L shifted the midpoint of the activation curve to
19.91.8 mV and accelerated the time course of channel activation (1064125 versus 82093 ms, n11,
P0.01). The envelope of the tail test demonstrated that at the very beginning of the pulses to 40 mV (25 ms), a
certain amount of block was apparent (31.39.9%). CA did not modify the voltage-dependence of HERG channel
inactivation (Vh60.85.6 versus 62.93.1 mV, n6, P0.05) or the kinetics of the reactivation process at any
potential tested. CA and aldosterone also blocked the native IKr in guinea-pig ventricular myocytes.
Conclusions—At concentrations reached after administration of therapeutic doses of SP, CA blocked the HERG channels
by binding to both the closed and open states of the channel. (Circulation. 2003;107:889-895.)
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Spironolactone (SP) is an aldosterone antagonist used inthe treatment of hypertension, congestive heart failure,
and cirrhotic ascites.1 In patients with advanced heart failure,
the Randomized Aldactone Evaluation Study (RALES)
showed that the addition of low-dose SP to an ACE inhibitor
and a loop diuretic improved survival.2 Furthermore, SP
reduced heart rate and improved heart rate variability and QT
dispersion in chronic heart failure.3 This latter result was
empirically attributed to the antagonism of the proarrhythmic
effects of aldosterone at the receptor level. In fact, aldoste-
rone causes sodium retention, myocardial fibrosis, and potas-
sium and magnesium depletion; potentiates the effects of
catecholamines; blunts the baroreflex response; and induces
ventricular arrhythmias.4
SP is extensively metabolized in humans, and79% of the
SP oral dose is converted to canrenone, its major biologically
active metabolite.5 Canrenone undergoes hydrolysis of its
-lactone ring to canrenoic acid (CA), which is water soluble.
Thus, after equilibrium, similar plasma concentrations of CA
and canrenone are reached. Two old studies demonstrated
that SP lengthened the duration and refractoriness of the
cardiac action potential,6,7 effects that were attributed to a
decrease in K conductance but that were not investigated
further.7 Thus, the effects of SP and CA on cardiac K
channels are currently unknown. Because the rapid compo-
nent of the delayed rectifier K current (IKr) carried by human
ether-a-go-go–related gene (HERG) channels plays a critical
role in the control of the action potential repolarization in
humans,8 the present study was undertaken to test whether SP
and CA modify HERG channels cloned from human heart
and stably expressed in a mammalian cell line.
Methods
Stably transfected CHO cells were cultured as previously de-
scribed9,10 and perfused with an external solution containing
(in mmol/L): NaCl 130, KCl 4, CaCl2 1, MgCl2 1, HEPES 10, and
glucose 10 (pH adjusted to 7.4 with NaOH). The internal solution
contained (in mmol/L): K-aspartate 80, KCl 42, KH2PO4 10, MgATP
5, phosphocreatine 3, HEPES 5, and EGTA 5 (pH adjusted to 7.2
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with KOH). Guinea pig ventricular myocytes were enzymatically
isolated and perfused with the same external solution supplemented
with 2 mmol/L CoCl2 and 30 mol/L tetrodotoxin.10 SP and CA
(Sigma) were dissolved in dimethyl sulfoxide and methanol, respec-
tively, to make 10 mmol/L stock solution.
HERG and IK currents were measured by use of the whole-cell and
the perforated-nystatin configurations of the patch-clamp technique,
respectively.10 Recordings were performed at 24°C to 25°C with
200B patch-clamp amplifiers. Capacitance and series resistance
compensation were optimized, and80% compensation was usually
obtained. Maximum HERG tail-current amplitudes averaged
52075 pA, mean uncompensated access resistance was 4.50.3
M, and cell capacitance was 14.90.7 pF (n22). In ventricular
myocytes, the effective access resistance averaged 12.80.9 M
and the larger current amplitude 26045 pA (n6). Thus, no
significant voltage errors (5 mV) were expected with the electrodes
used (tip resistance 3 M). The inhibitory concentration at which
50% of block was achieved, IC50, and Hill coefficient, nH, were
obtained from fitting the fractional block, f, at various drug concen-
trations [D] to the Hill equation:
f1/{1(IC50/[D])nH}.
Results are expressed as meanSEM. Data were compared
by ANOVA followed by the Newman-Keuls test. A value of
P0.05 was considered significant.
Results
Concentration-Dependent Effects of SP and CA
Figure 1 summarizes the effects of 1 mol/L SP on HERG
currents. Families of current traces are shown for control
conditions and after 10 minutes of exposure to SP obtained by
applying 5-second pulses to voltages between 80 and 60
mV in 10 mV increments (A). The holding potential was
fixed at 80 mV, and tail currents were recorded on
repolarization to 60 mV for 5 seconds. SP decreased both
the outward and the tail currents and accelerated the time
course of channel activation measured from the exponential
fits of the current traces elicited at 0 mV (Table). Further-
more, SP did not modify the decline of tail currents elicited
Figure 1. A, Current traces obtained with voltage protocol illustrated at top for control conditions and with 1 mol/L SP. B,
Concentration-response relation for block of HERG tail currents elicited on repolarization to 60 mV after 5-second pulses to 60 mV.
Continuous line represents fit of data to Hill equation. Each point represents meanSEM of 4 experiments. C, Averaged current-
voltage relationship 5-second isochronal in absence and in presence of SP. D, Averaged activation curves as calculated from peak tail-
current amplitudes under control and SP. Dashed line represents normalized activation curve in presence of SP. Squares represent
fractional tail-current block as a function of membrane potential. C and D, points represent meanSEM of 6 experiments. *P0.05 vs
control.
Effects of SP and CA on the Characteristics of HERG Currents
Control
SP,
1 mol/L Control
CA,
1 nmol/L
Vh (activation), mV 13.13.4 18.93.6* 17.12.3 19.91.8*
k (activation), mV 8.40.2 8.90.4 8.70.5 8.90.6
activation, ms 1354215 998170* 1064125 82093*
fdeactivation, ms 308.426.4 364.239.6 323.934.5 470.145.6*
sdeactivation, ms 147095 1752226 1833255 2196270*
Data are meanSEM of 6 and 11 experiments in the presence of SP and CA, respectively.
*P0.05 vs control.
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on repolarization to 60 mV after pulses to 60 mV, and
thus, both the fast (f) and the slow (s) time constants of
deactivation remained unaltered (Table). The concentration-
dependence of the blockade measured on the peak tail current
elicited on repolarization after pulses to60 mV was fitted to
the Hill equation and yielded an IC50 of 23.01.5 mol/L
(nH0.80). Current-voltage plots of steady-state current
present at the end of the depolarizing step (current-voltage
relationship) and peak tail current (activation curve) are
depicted in Figure 1, C and D, respectively. In the presence of
SP, steady-state current amplitude elicited at 0 mV was
reduced by 18.94.2% (n6, P0.05). In 6 cells, SP shifted
the midpoint of the activation curve (D, continuous lines) to
more negative potentials but did not modify the slope factor
(Table). The squares in D represent the fractional tail-current
block as a function of the membrane potential. The results
indicated that blockade appeared at the range of membrane
potentials coinciding with that at which channel activation
occurred, and thereafter it remained constant, reaching
24.73.8% at 60 mV (n6, P0.05).
Figure 2, A and B, shows current traces obtained in the
absence and in the presence, respectively, of 1 nmol/L CA.
CA also decreased both the outward and the tail HERG
currents, and these effects were almost completely reversed
after washout (Figure 2C). Figure 2D shows the extent of
block of tail currents elicited on repolarization after pulses to
60 mV by CA (concentration-response curve). Surpris-
ingly, the percentage of tail-current block remained almost
constant for concentrations ranging from 0.01 nmol/L to 1
mol/L, and thereafter, it increased as the concentration of
CA was increased. The IC50 and the nH obtained by fitting the
Hill equation to the data averaged 104.31.2 mol/L and
1.90.6, respectively. To analyze the frequency-, time-, and
voltage-dependence of CA-induced block, the concentration
of 1 nmol/L was selected. CA decreased the current ampli-
tude at potentials ranging from 10 to 30 mV, reaching
22.71.5% of block at 0 mV (n11, P0.05). CA also
decreased the tail-current amplitude recorded on repolariza-
tion to 60 mV (Figure 2F) and shifted the midpoint of the
activation curve toward more negative potentials without
modifying the slope factor (Table). In F, the squares represent
the fractional tail-current block as a function of the membrane
potential. The blockade was already apparent before channel
activation reached saturation, and it remained constant in a
wide range of potentials, averaging 18.34.5% and
22.75.7% at 30 and 60 mV, respectively (n11,
P0.05).
To analyze whether the CA-induced block was frequency-
dependent, trains of 200-ms pulses to 60 mV at 1 or 2 Hz
were applied in 2 different groups of cells (Figure 3, A and
B). Under control conditions, the tail-current amplitude re-
mained unchanged both at 1 and at 2 Hz, and CA-induced
block was almost fully developed with the first pulse of the
train. C represents the ratio of the tail-current amplitude as a
function of the number of pulses during the train. CA
decreased the tail amplitude of the first and the last pulse of
trains at 1 and 2 Hz to a similar extent, which indicated that
CA did not produce a frequency-dependent block of HERG
channels.
Figure 2. A, Current traces obtained with voltage protocol illustrated at top for control conditions and with CA (B). C, Superimposed
current traces obtained in absence and in presence of CA and after washout with drug-free solution. D, Concentration-response rela-
tionship for block of HERG tail currents elicited on repolarization to 60 mV after 5-second pulses to 60 mV. Continuous line repre-
sents fit of data to Hill equation. Each point represents meanSEM of 5 experiments. E, Averaged current-voltage relationship
5-second isochronal in absence and in presence of CA. F, Averaged activation curves as calculated from peak tail-current amplitudes
under control and CA. Dashed line represents normalized activation curve in presence of CA. Squares represent fractional tail-current
block as a function of membrane potential. E and F, Points represent meanSEM of 11 experiments. *P0.05 vs control.
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Time-Dependent Inhibition by CA
Time-dependent inhibition of HERG channels by CA was
first measured by use of an envelope of tail test (Figure 4, A
and B). Tail currents were generated on repolarization to60
mV after application of voltage steps of increasing duration to
40 mV. Both in the absence and in the presence of CA tail
current amplitudes increased in a monoexponential fashion as
the pulse was lengthened (Control192.911.2 and
CA122.28.5 ms; n11, P0.05). Fractional block as a
function of the pulse duration is shown in Figure 4, C and D.
The results suggested that at the beginning of the depolariza-
tion, a certain amount of block was apparent (31.39.9%),
which decreased within the first 100 ms (18.36.8%; n6,
P0.05). Thereafter, the blockade slightly increased with the
depolarization, but this increase did not reach statistical
significance. The onset of the CA-induced block was well
fitted with a single exponential function, and the block
averaged 349102 ms (n6).
Figure 4E shows superimposed current traces obtained by
use of a protocol previously described by Zhang et al.11 We
analyzed the development of block during a 200-ms pulse to
0 mV preceded by a 5-ms depolarization to180 mV. Under
these conditions, the current at 0 mV was nearly constant, and
tail current was recorded with the subsequent repolarizing
step to 60 mV. Once again, virtually all of the final effect
of CA was already present at the beginning of the step, ie, CA
simply scaled down the current at 0 mV and the tail current
by 17.31.5% and 20.61.9%, respectively (n6, P0.05).
The time-dependence of the CA-induced block was also
studied from the exponential fits of the current traces elicited
at 0 mV, and the results demonstrated that CA accelerated the
time course of current activation (Table). Deactivation kinet-
ics of tail currents elicited on return to 60 mV after pulses
to 60 mV was slowed in the presence of CA (Table). In
contrast, deactivation kinetics of tail currents after pulses to 0
mV was not modified. In fact, both the fast and the slow time
constants of deactivation in the absence (f315.932.6 and
s1808118 ms) and the presence (f342.223.1 and
s1853137 ms) of CA remained unaltered (n11,
P0.05). Figure 4F shows the ratio of tail currents elicited on
return to 60 mV after pulses to 0 mV. Within the first
second of repolarization, the blockade increased slightly, and
thereafter it decreased progressively. The time-dependent
effects of CA suggested that it blocked HERG channels in the
closed and in the open state.
Effects of CA on the Inactivation and Reactivation
of HERG Channels
We next looked for changes in the steady-state inactivation
(availability) of the channels. The protocol used is described
in Figure 5A, together with typical current records obtained in
the absence of CA. After a 1-second pulse to 40 mV to
activate the channels, the membrane voltage was stepped
briefly to various test voltages and then to 40 mV. During
the brief step, the inactivation process relaxed rapidly to the
steady-state level appropriate to the test potential. The initial
current on stepping to 40 mV gave the relative number of
open channels. Figure 5B represents the initial current am-
plitude at 40 mV (arrow in A) against the interpulse
potential. At negative voltages, the currents decline because
significant closing of channels occurred through deactivation.
Thus, in Figure 5C, this was corrected for by extrapolating
the exponential falling phase back to the start of the negative
voltage step and applying the same relative correction to the
initial outward current. This procedure was described previ-
ously for the same purpose.12 The Vh of the corrected for
closing, and the uncorrected inactivation curves averaged
60.85.6 mV (k21.11.5 mV) and 49.93.0 mV
(k16.31.8 mV), respectively. CA did not modify the
voltage-dependence of HERG channel inactivation; thus, the
Vh of the corrected-for closing inactivation curves averaged
62.93.1 mV (k21.61.9 mV; n6, P0.05), whereas
that of the uncorrected averaged 51.71.9 mV
(k16.51.9; n6, P0.05). Figure 5D represents the
fractional block as a function of the interpulse potential and
indicated that the blockade was not significantly modified by
the channel inactivation.
To assess whether CA altered the recovery from inactiva-
tion, a protocol similar to that of Spector et al13 was used. The
membrane was repolarized 100 ms to voltages ranging from
Figure 3. Voltage-clamp pulse trains (protocol shown in inset)
were applied at (A) 1 and (B) 2 Hz. Mean tail-current amplitude
in absence and in presence of 1 nmol/L CA were plotted vs
pulse number. C, Ratio of tail-current amplitudes in absence
and presence of CA as a function of pulse number.
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120 to 60 mV after a 500-ms pulse to 50 mV.
Representative examples of the time course of recovery from
inactivation and its fitting to a monoexponential process are
shown in Figure 6E. The mean time constants for recovery
from inactivation in the absence and the presence of CA were
plotted against voltage in Figure 6F. CA did not modify the
kinetics of the reactivation process at any of the potentials
tested.
Effects of CA on Native IKr
Figure 6A shows the IK recorded on isolated guinea-pig
ventricular myocytes in the presence of 2 mmol/L Co2-
containing solution. After 5 seconds of depolarization to50
mV, the cell was repolarized at 0 mV for 10 seconds. Under
these conditions, the IKs was deactivated, and hyperpolariza-
tion to 60 mV elicited a tail current, which is caused
primarily by the IKr because of its marked inward rectifier
properties. CA, 50 mol/L, decreased the maximum and the
tail current elicited by the first depolarizing pulse
(36.24.6%, n4) and the tail amplitude obtained at 60
mV (31.65.9%). Figure 6B shows that 0.1 mol/L aldoste-
rone decreased the maximum current elicited by the depolar-
ization to 50 mV (22.03.6%) and the tail current on
repolarization to 60 mV (13.52.1%, n4). Addition of
CA in the presence of aldosterone further decreased the
maximum and the tail current elicited on repolarization to
60 mV (53.33.2%, n4).
Discussion
Our results demonstrate for the first time that SP and its
metabolite CA directly block HERG channels. It should be
stressed that the experiments were carried out in the absence
of aldosterone, and thus, the observed effects are not attrib-
utable to antagonism of its effects at the aldosterone receptor
level. Furthermore, both CA and aldosterone blocked the
native IKs and IKr currents, and the effects of CA on IKr were
comparable to those produced on HERG currents.
The concentration-dependent effects of CA on HERG
channels are unusual, and at a wide range of concentrations
(0.01 to 1000 nmol/L), blockade was almost concentration-
independent. The reason for this behavior is unknown, but it
may be related to the anionic nature of both SP and CA. In
Figure 4. Envelope of tail-current test under control conditions and with 1 nmol/L CA. Pulses to 40 mV of increasing duration (25 ms
to 5 seconds) were applied every 30 seconds. Peak tail current after return to 60 mV was plotted as a function of test pulse duration
in A. Continuous lines represent monoexponential that fits experimental data. B, Expanded time scale of data presented in A. C, Frac-
tional tail-current block produced by CA as a function of test pulse duration. Continuous line represents monoexponential that fits
experimental data. D, Expanded time scale of data presented in C. A through D, Points represent meanSEM of 6 experiments. E,
Superimposed current traces in control conditions and in presence of CA are shown. HERG current was rapidly activated from a hold-
ing potential of 80 mV by a 5-ms step to 180 mV followed by a step to 0 mV. Tail currents were observed on repolarization to 60
mV. F, Relative tail current estimated by ratio of CA-sensitive current and current in control conditions. Tail currents were recorded on
repolarization to 60 mV after 5-second pulses to 0 mV. Points are mean and lines SEM of 11 experiments.
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fact, this is the first report of a concentration-dependent
interaction between an anionic drug and the HERG channels.
Further studies are necessary to elucidate whether only 1
molecule of CA binds to the pore cavity of the HERG
channels to block the K efflux.
The effects of CA on HERG channels were voltage- and
frequency-independent, indicating that CA blocks HERG
channels in the closed state or/and preferentially binds to the
open state, with very fast kinetics of development of block.
Results of the envelope of tail test suggested that blockade
appeared before channels activated and that channel activa-
tion led to only a small increase in block. Conversely, at the
beginning of the tail currents elicited on repolarization after
pulses to 0 mV, a small increase of block was observed, and
thereafter, as the closing progressed, the blockade decreased.
Moreover, no time-dependent development of block was
resolved when currents at 0 mV were recorded after strong
and brief depolarizing pulses. All these results suggested that
CA binds to a closed state (or active but not open) from which
opening proceeds, as well as to the open state of the HERG
channels. However, CA did not modify the voltage-
dependence of inactivation or the time course of reactivation
of HERG channels, which indicated that CA did not bind to
the inactivate state of the channel.
SP also decreased HERG currents in a concentration-
dependent manner, its effects being voltage-independent after
HERG channel activation reached saturation. Because SP is
metabolized too rapidly to be detected in plasma, no further
effort was made to determine the possible state-dependence
of the blockade observed.
Clinical Implications
After oral administration, SP is metabolized rapidly (half-life
1.5 hours), whereas its metabolites (canrenone and/or CA)
have considerably longer half-life values (16.5 hours). Peak
plasma concentration of canrenone after administration of
therapeutic doses of SP range between 0.3 and 1.6 mol/L.
Canrenone is extensively (98%) bound to plasma proteins and
Figure 5. A, Current records obtained with protocol used to assess steady-state inactivation. After inactivation was allowed to relax to
steady-state at potentials ranging from 130 to 20 mV during 20 ms, membrane voltage was stepped to 40 mV for 225 ms. B,
Steady-state inactivation from A. Initial current (arrow in A) obtained in absence and in presence of 1 nmol/L CA was plotted as a func-
tion of previous voltage step. C, Corrected for closing inactivation curve obtained in presence and in absence of CA. D, Fractional
block for both uncorrected and corrected for closing initial current amplitudes as a function of interpulse potential. E, Current traces
recorded in absence and in presence of CA with protocol used to assess recovery from inactivation. Time course of recovery from
inactivation was measured by fitting exponential functions (continuous lines) to tail currents elicited after repolarization from a 500-ms
pulse to 50 mV from a holding potential of 80 mV. F, Mean time constant values of recovery of inactivation in control conditions
and in presence of CA as a function of membrane potential. B through D and F, Points represent meanSEM of 6 experiments.
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is in enzymatic equilibrium with CA, producing peak free
plasma concentrations of CA of 3 to 16 nmol/L.5 Therefore,
our study demonstrated that at concentrations within the
therapeutic range, CA blocks HERG channels. As a conse-
quence, a prolongation of the atrial and ventricular action
potentials would be expected, an effect already described in
multicellular preparations.6,7 Prolongation of the duration of
the cardiac action potential (APD) and refractoriness has been
recognized as an antiarrhythmic effect. However, blockade of
HERG channels can lead, under some circumstances, espe-
cially in the setting of hypokalemia, bradycardia, or both, to
an excessive prolongation of the APD and of the QT interval.
This latter effect is considered to be proarrhythmic, because it
might produce polymorphic ventricular tachycardias known
as torsades de pointes.14 Conversely, SP antagonized the
hypokalemia and hypomagnesemia produced by aldosterone,
an effect that may blunt the blockade of HERG channels.15
Furthermore, the blockade of Ca2 channels produced by SP16
would shorten the APD and suppress early afterdepolariza-
tions. Therefore, further studies are needed to analyze the
resultant effects of SP/CA on human cardiac repolarization
and its possible clinical implications.
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